Additional Listing

1 Sep 2005 11:14

GW Pharmaceuticals PLC01 September 2005 GW Pharmaceuticals plc ("the Company") Option exercise and application to AIM Pursuant to the exercise by a consultant of an option over 12,275 new ordinaryshares of 0.1 pence each in the Company ("New Ordinary Shares") at a price of20.52 pence per share, the Company has today issued and allotted the NewOrdinary Shares and applied for them to be admitted to the AlternativeInvestment Market of the London Stock Exchange. Such admission is expected tobecome effective on 9th September 2005. This information is provided by RNS The company news service from the London Stock Exchange